Nippon India Pharma Fund
- Sectoral
- Wild
- Nippon India Mutual Fund
- Direct · Growth
NAV ₹666.34 · 20 Nov
| Date | NAV |
|---|---|
| 20 Nov 2023 | ₹405.82 |
| 5 Jan 2024 | ₹445.38 |
| 22 Feb 2024 | ₹478.52 |
| 12 Apr 2024 | ₹469.54 |
| 31 May 2024 | ₹476.38 |
| 18 Jul 2024 | ₹514.09 |
| 3 Sept 2024 | ₹570.78 |
| 18 Oct 2024 | ₹578.67 |
| 6 Dec 2024 | ₹572.51 |
| 23 Jan 2025 | ₹552.36 |
| 11 Mar 2025 | ₹515.87 |
| 30 Apr 2025 | ₹552.45 |
| 16 Jun 2025 | ₹574.29 |
| 30 Jul 2025 | ₹598.09 |
| 16 Sept 2025 | ₹577.96 |
| 6 Nov 2025 | ₹574.04 |
| 22 Dec 2025 | ₹573.96 |
| 9 Feb 2026 | ₹562.42 |
| 27 Mar 2026 | ₹555.47 |
| 15 May 2026 | ₹611.46 |
| 2 Jul 2026 | ₹626.26 |
| 18 Aug 2026 | ₹643.34 |
| 5 Oct 2026 | ₹621.32 |
| 20 Nov 2026 | ₹666.34 |
An open-ended sectoral fund from Nippon India Mutual Fund. Running since June 2004 · Direct plan since January 2013. Figures for the Direct plan, Growth option.
- Fund size
- ₹9,087 Cr
- Category median ₹569 Cr
- Expense ratio
- 0.99%
- Category 1.01%
- 5Y a year
- 15.4%
- Category 14.3%
- Deepest fall, whole history
- −21.2%
- Now 0.0%
- Any 3 years, a year
- −1.3% to 31.9%
- Positive in 561 of 569
- Top 10 holdings
- 57.2%
- 40 holdings
Returns against the category
| Period | This fundFund | Category medianCategory |
|---|---|---|
| 1 month1M | 11.4% | 10.0% |
| 3 months3M | 3.7% | 2.3% |
| 6 months6M | 8.6% | 10.3% |
| 1 year1Y | 15.3% | 4.9% |
| 3 years (a year)3Y | 18.0% | 14.6% |
| 5 years (a year)5Y | 15.4% | 14.3% |
| 10 years (a year)10Y | 16.6% | 16.5% |
| Since January 2013 (a year)Launch | – | 12.7% |
Ups and downs
Now · deepest ever −21.2% · chart from January 2013
| Date | Below peak |
|---|---|
| 1 Jan 2013 | 0.0% |
| 5 Aug 2013 | −5.5% |
| 12 Mar 2014 | −3.7% |
| 28 Oct 2014 | −0.7% |
| 8 Jun 2015 | −11.9% |
| 13 Jan 2016 | −10.3% |
| 19 Aug 2016 | −9.6% |
| 29 Mar 2017 | −13.0% |
| 6 Nov 2017 | −9.7% |
| 8 Jun 2018 | −10.5% |
| 16 Jan 2019 | −7.7% |
| 23 Aug 2019 | −16.4% |
| 3 Apr 2020 | −11.4% |
| 6 Nov 2020 | −4.1% |
| 16 Jun 2021 | −1.1% |
| 20 Jan 2022 | −6.6% |
| 29 Aug 2022 | −13.0% |
| 6 Apr 2023 | −12.2% |
| 13 Nov 2023 | −0.1% |
| 25 Jun 2024 | −1.8% |
| 29 Jan 2025 | −10.5% |
| 5 Sept 2025 | −4.3% |
| 16 Apr 2026 | −5.7% |
| 20 Nov 2026 | 0.0% |
- Volatility (3Y)
- 13.9%standard deviation, a year
- Deepest fall
- −21.2%from a peak, whole history
- Sharpe ratio (3Y)
- 0.86return per unit of volatility
Every three-year period
The yearly return of money held for exactly three years, started on each of 569 different dates.
- Worst
- −1.3%a year
- Median
- 19.8%a year
- Best
- 31.9%a year
- Periods with a gain
- 98.6%
What it holds
Portfolio as disclosed for October 2026: 40 holdings, the ten largest 57.2% of the fund.
- Equity99.6%
- Cash and equivalents0.4%
- Large cap29.6%
- Mid cap40.8%
- Small cap28.7%
- Health Care95.8%
- Consumer Discretionary2.3%
- Industrials1.6%
- Others0.5%
Largest holdings
- Sun Pharmaceutical Industries LimitedPharmaceuticals & Biotechnology11.55%
- Divi's Laboratories LimitedPharmaceuticals & Biotechnology6.73%
- Cipla LimitedPharmaceuticals & Biotechnology6.21%
- Lupin LimitedPharmaceuticals & Biotechnology6.16%
- Dr. Reddy's Laboratories LimitedPharmaceuticals & Biotechnology6.13%
- Apollo Hospitals Enterprise LimitedHealthcare Services5.10%
- Mankind Pharma LimitedPharmaceuticals & Biotechnology4.40%
- Sai Life Sciences LimitedPharmaceuticals & Biotechnology4.04%
- Ajanta Pharma LimitedPharmaceuticals & Biotechnology3.53%
- Max Healthcare Institute LimitedHealthcare Services3.31%
Fund size over time
From ₹8,114 Cr in September 2025; all plans together
| Month end | Fund size |
|---|---|
| 30 Sept 2025 | ₹8,114 Cr |
| 31 Oct 2025 | ₹8,346 Cr |
| 30 Nov 2025 | ₹8,459 Cr |
| 31 Dec 2025 | ₹8,265 Cr |
| 31 Jan 2026 | ₹7,875 Cr |
| 28 Feb 2026 | ₹8,306 Cr |
| 31 Mar 2026 | ₹7,898 Cr |
| 30 Apr 2026 | ₹8,365 Cr |
| 31 May 2026 | ₹8,636 Cr |
| 30 Jun 2026 | ₹9,044 Cr |
| 31 Jul 2026 | ₹9,279 Cr |
| 31 Aug 2026 | ₹9,479 Cr |
| 30 Sept 2026 | ₹9,166 Cr |
| 31 Oct 2026 | ₹9,087 Cr |
Key facts
- Plan and option
- Direct plan, Growth option
- Launched
- 5 Jun 2004
- Direct plan since
- 1 Jan 2013
- Benchmark
- BSE Health Care - TRI
- Fund manager
- Sailesh Raj Bhan
- Exit load
- 1% if redeemed or switched out on or before completion of 1 month from the date of allotment of units.Nil, thereafter.
- Minimum investment
- SIP ₹100 a month · one-time ₹5,000
- ISIN
- INF204K01I50
Other Sectoral funds
- ICICI Prudential Technology Fund6.3% 3Y a year₹13,154 Cr
- ICICI Prudential Banking and Financial Services Fund13.3% 3Y a year₹10,709 Cr
- SBI BANKING & FINANCIAL SERVICES FUND18.8% 3Y a year₹10,505 Cr
- Tata Digital India Fund4.4% 3Y a year₹9,985 Cr
- ICICI Prudential Infrastructure Fund15.4% 3Y a year₹7,750 Cr
- SBI Energy Opportunities Fund– 3Y a year₹7,548 Cr
The largest other funds in the category by fund size, not a ranking. All Sectoral funds · Compare side by side
Questions about Nippon India Pharma Fund
What is the expense ratio of Nippon India Pharma Fund?
The Direct plan's expense ratio is 0.99% a year as of 31 Oct 2026. It is taken out of the fund's assets every day, so the NAV and the returns shown are already after it.
How large is Nippon India Pharma Fund?
Nippon India Pharma Fund manages ₹9,087 Cr as of 31 Oct 2026.
What returns has Nippon India Pharma Fund given?
1 year: 15.3% (category median 4.9%); three years: 18.0% a year (category median 14.6%); five years: 15.4% a year (category median 14.3%). Figures are for the Direct plan, Growth option, up to 20 Nov 2026. Past returns do not guarantee future returns.
How much does Nippon India Pharma Fund go up and down?
Over three years its returns had a standard deviation of 13.9% a year. Its largest fall from a peak over its whole history was 21.2%.
What is the benchmark of Nippon India Pharma Fund?
The fund measures itself against the BSE Health Care - TRI.
Who manages Nippon India Pharma Fund?
Sailesh Raj Bhan manages the fund.
Is there an exit load on Nippon India Pharma Fund?
Exit load: 1% if redeemed or switched out on or before completion of 1 month from the date of allotment of units.Nil, thereafter..
What is the minimum investment in Nippon India Pharma Fund?
A SIP can start from ₹100 a month. A one-time investment can start from ₹5,000.
About the fund house, Nippon India Mutual Fund
Nippon India Mutual Fund runs 77 funds on this site, managing ₹5,26,064 Cr together.
